Send feedback

PANK2 p.Asp46Val

c.137A>T · rs148036492 · VCV425264

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 10 submitters
AlphaMissense
likely benign
0.0965 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.214%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
pantothenate kinase-associated neurodegeneration

Computational evidence

Protein change
AlphaMissense0.0965likely benign
REVEL0.161moderately benign-leaning
SaProtLLR -5.03tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.23GERP -3.7
Overall
CADD2.76PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.214% European (non-Finnish) · 2,522/1,179,748 alleles
Filtering AF 0.207% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.204%
Overall 0.249% 4,016/1,613,306 alleles · rare exomes 3,521/1,460,976 · genomes 495/152,330 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 2.07% 48
European (non-Finnish)grpmax 0.214% 468
Remaining individualsnot grpmax-eligible 0.152% 657
Admixed American 0.0867% 1,153
African / African-American 0.024% 4,169
Ashkenazi Jewishnot grpmax-eligible 0.0135% 7,390
South Asian 0.0022% 45,366

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PANK2
Protein
p.Asp46Val
Coding
c.137A>T
MANE Select
NM_001386393 · reported on NM_153638
dbSNP
rs148036492
Type
single nucleotide variant
Location
chr20:3889237 (GRCh38)
Gene constraint
LOEUF 1.115 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 73.99 · 1 PDB
Residue 46
the 'disordered' region
Full PANK2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

pantothenate kinase-associated neurodegeneration — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Pantothenate kinase-associated neurodegeneration (Orphanet):

Inheritance
Autosomal recessive
Onset
All ages
Prevalence
1-9 / 1 000 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pank2-p-asp46val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown